Literature DB >> 7020965

Determination of captopril in blood and urine by high-performance liquid chromatography.

Y Kawahara, M Hisaoka, Y Yamazaki, A Inage, T Morioka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7020965     DOI: 10.1248/cpb.29.150

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  7 in total

1.  The effect of pH on the buccal and sublingual absorption of captopril.

Authors:  J C McElnay; T A al-Furaih; C M Hughes; M G Scott; J S Elborn; D P Nicholls
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

2.  Kinetics and mechanism of captopril oxidation in aqueous solution under controlled oxygen partial pressure.

Authors:  T Y Lee; R E Notari
Journal:  Pharm Res       Date:  1987-04       Impact factor: 4.200

Review 3.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

4.  Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.

Authors:  N Hockings; A A Ajayi; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

5.  Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients.

Authors:  C Richer; B Giroux; P F Plouin; B Maarek; J F Giudicelli
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

6.  Influence of chronic renal failure on captopril pharmacokinetics and clinical and biological effects in hypertensive patients.

Authors:  J F Giudicelli; M Chaignon; C Richer; B Giroux; J Guedon
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

Review 7.  Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases.

Authors:  K L Duchin; D N McKinstry; A I Cohen; B H Migdalof
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.